Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (869) Arrow Down
Filter Results: (869) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (869)
    • People  (1)
    • News  (139)
    • Research  (583)
    • Events  (1)
    • Multimedia  (7)
  • Faculty Publications  (329)

Show Results For

  • All HBS Web  (869)
    • People  (1)
    • News  (139)
    • Research  (583)
    • Events  (1)
    • Multimedia  (7)
  • Faculty Publications  (329)
← Page 19 of 869 Results →
  • 30 Aug 2016
  • First Look

August 30, 2016

Rapidly Developed Patient-Centered Outcome Measures By: Shah, Kevin P., Tracy E. Spinks, and Thomas W. Feeley Abstract—In 2014, The University of Texas MD Anderson Cancer Center created a streamlined process for developing measure sets... View Details
Keywords: Carmen Nobel
  • 2018
  • Working Paper

Zig-Zagging Your Way to Transformative Impact

By: V. Kasturi Rangan and Tricia Gregg
Achieving transformative impact has been much discussed by social entrepreneurs, funders, and consultants. These discussions have focused on issues of increasing impact and scale, but often with no clear distinction between the two terms. In order to provide clarity,... View Details
Keywords: Social Entrepreneurship; Performance Efficiency; Growth and Development; Outcome or Result; Strategy
Citation
Related
Rangan, V. Kasturi, and Tricia Gregg. "Zig-Zagging Your Way to Transformative Impact." Harvard Business School Working Paper, No. 18-062, January 2018.
  • July 2019 (Revised November 2022)
  • Case

Momofuku Ando and the Globalization of Noodles

By: Geoffrey Jones and Megumi Takada
This case examines the entrepreneurial career of Momofuku Ando, the Taiwanese-born Japanese entrepreneur who pioneered instant boodles with his Chicken Ramen (1958) and Cup Noodle (1971) products. It begins by reviewing his many previous unsuccessful ventures,... View Details
Keywords: Entrepreneurship; Personal Development and Career; Failure; Success; Globalization; Corporate Social Responsibility and Impact; Food and Beverage Industry; Japan
Citation
Educators
Purchase
Related
Jones, Geoffrey, and Megumi Takada. "Momofuku Ando and the Globalization of Noodles." Harvard Business School Case 320-006, July 2019. (Revised November 2022.)
  • 17 May 2016
  • First Look

May 17, 2016

2016 New York: Oxford University Press Consumers, Corporations, and Public Health: A Case-Based Approach to Sustainable Business By: John A. Quelch. Abstract—The public health footprint associated with corporate behavior has come under... View Details
Keywords: Sean Silverthorne
  • Web

Placement - Doctoral

Science Dissertation: Essays on Enforcement and Disclosure Advisors: Eugene F. Soltes (Co-Chair), Suraj Srinivasan (Co-Chair), and Charles C.Y. Wang 2020 Wei Cai Accounting & Management, 2020 Placement: Columbia Business School, Accounting Department Dissertation:... View Details
  • 16 Dec 2014
  • First Look

First Look: December 16

opposed to increased levels of funding from the governments. Analyses of 2011 and 2012 state pension reforms confirm that states opposed to accounting reform are more likely to cut pension benefits. Download working paper: http://ssrn.com/abstract=2533492 How Should We... View Details
Keywords: Sean Silverthorne
  • June 2024
  • Case

Aidoc: Building a Hospital-Centric AI Platform

By: Ariel D. Stern and Susan Pinckney
In 2023, Israel-based AI health care company Aidoc evaluated its future. The company, founded in 2016, had grown from commercializing a single AI product for radiologists to a software platform that could detect 20 conditions and immediately notify care teams of... View Details
Keywords: Business Growth and Maturation; Business Model; Business Organization; Business Startups; Disruption; Cost vs Benefits; Decision Choices and Conditions; Decisions; Private Sector; Entrepreneurial Finance; Global Range; Global Strategy; Globalized Markets and Industries; Governance Compliance; Governance Controls; Governing and Advisory Boards; Policy; Medical Specialties; AI and Machine Learning; Digital Platforms; Digital Transformation; Technology Adoption; Disruptive Innovation; Innovation and Management; Innovation Strategy; Laws and Statutes; Growth and Development Strategy; Growth Management; Distribution; Product Development; Success; Performance Efficiency; Strategic Planning; Research and Development; Risk and Uncertainty; Business Strategy; Competitive Advantage; Value Creation; Health Industry; Israel
Citation
Educators
Purchase
Related
Stern, Ariel D., and Susan Pinckney. "Aidoc: Building a Hospital-Centric AI Platform." Harvard Business School Case 624-046, June 2024.
  • 30 Mar 2010
  • First Look

First Look: March 30

outcomes salient (Burns & Corpus, 2004), the bias did not emerge when the presentation did not draw attention to recent outcomes. Fixing Health Care on the Front Lines Author:Richard M.J. Bohmer... View Details
Keywords: Sean Silverthorne
  • April 2014 (Revised July 2015)
  • Case

Sanofi Pasteur: The Dengue Vaccine Dilemma

By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud
In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details
Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France
Citation
Educators
Purchase
Related
Rangan, V. Kasturi, David E. Bloom, Vincent Dessain, and Emilie Billaud. "Sanofi Pasteur: The Dengue Vaccine Dilemma." Harvard Business School Case 514-074, April 2014. (Revised July 2015.)
  • 2014
  • Working Paper

Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms

By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Citation
Read Now
Related
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
  • Program

Growing as a Purposeful Leader

corporate purpose in every action they take Unleash "human magic"—and business results—through purposeful leadership Shape an environment that can allow every employee to be the biggest, best version of themselves and drive exceptional View Details
  • January 2018
  • Article

The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial

By: Leslie K. John, Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein and Kevin Volpp
Purpose: We tested the effects of employer subsidies on employee enrollment, attendance, and weight loss in a nationally-available weight management program.
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details
Keywords: Affordable Care Act (ACA); Subsidies; Weight Loss; Obesity; Incentives; Behavioral Economics; Motivation and Incentives; Behavior; Health Disorders; Health Care and Treatment; Compensation and Benefits; United States
Citation
Find at Harvard
Read Now
Related
John, Leslie K., Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein, and Kevin Volpp. "The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial." American Journal of Health Promotion 32, no. 1 (January 2018): 170–176.
  • 21 Nov 2017
  • First Look

First Look at New Research and Ideas, November 21, 2017

available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317078-PDF-ENG Harvard Business School Case 618-008 CareMore Health System CareMore Health System—a physician-founded care delivery... View Details
Keywords: Sean Silverthorne
  • 30 Jul 2013
  • First Look

First Look: July 30

Publications 2013 pub Rx: Human Nature: How Behavioral Economics Is Promoting Better Health Around the World By: Ashraf, Nava Abstract—Why doesn't a woman who continues to have unwanted pregnancies avail herself of the free contraception... View Details
Keywords: Anna Secino
  • 27 Sep 2013
  • Working Paper Summaries

The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance

Keywords: by Claire Senot, Aravind Chandrasekaran, Peter T. Ward & Anita L. Tucker; Health
  • 26 Mar 2019
  • First Look

New Research and Ideas, March 26, 2019

record health worker attendance and patient adherence to protocol, and they automatically prompt follow-up treatment. We combine data from surveys, independent field visits, and government registers to identify impacts on TB-control View Details
Keywords: Dina Gerdeman
  • July 2019
  • Article

The Impact of Price Regulation on the Availability of New Drugs in Germany

By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari
The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details
Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany
Citation
Find at Harvard
Read Now
Related
Stern, Ariel Dora, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim, and Ameet Sarpatwari. "The Impact of Price Regulation on the Availability of New Drugs in Germany." Health Affairs 38, no. 7 (July 2019): 1182–1187.
  • Program

PLD Module 5

strategic decisions with a deeper understanding of the financial implications Help your company deliver greater value to a wide range of stakeholders Navigate high-stakes negotiations and drive better outcomes Expand your personal and... View Details
  • July 2021
  • Article

Electronic Trace Data and Legal Outcomes: The Effect of Electronic Medical Records on Malpractice Claim Resolution Time

By: Sam Ransbotham, Eric Overby and Michael C. Jernigan
Information systems generate copious trace data about what individuals do and when they do it. Trace data may affect the resolution of lawsuits by, for example, changing the time needed for legal discovery. Trace data might speed resolution by clarifying what events... View Details
Keywords: Analytics and Data Science; Lawsuits and Litigation; Digital Transformation; Welfare; Health Industry
Citation
Find at Harvard
Purchase
Related
Ransbotham, Sam, Eric Overby, and Michael C. Jernigan. "Electronic Trace Data and Legal Outcomes: The Effect of Electronic Medical Records on Malpractice Claim Resolution Time." Management Science 67, no. 7 (July 2021): 4341–4361.
  • 2017
  • Article

Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals

By: Joshua W. Buckholtz, Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan and Arielle Baskin-Sommers
Antisocial behavior is often assumed to reflect aberrant risk processing. However, many of the most significant forms of antisocial behavior, including crime, reflect the outcomes of decisions made under conditions of ambiguity rather than risk. While risk and... View Details
Keywords: Ambiguity; Neuroscience; Neuroeconomics; Choice; Psychology; Decision Choice And Uncertainty; Behavior; Decision Choices and Conditions; Cost vs Benefits; Health Disorders
Citation
Read Now
Related
Buckholtz, Joshua W., Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan, and Arielle Baskin-Sommers. "Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals." Art. 2030. Scientific Reports 7 (2017).
  • ←
  • 19
  • 20
  • …
  • 43
  • 44
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.